SST and Alzheimer disease: We note that we did not see strong evidence for lower expression of SST mRNA among SST-annotated nuclei in AD after covarying for SST cell proportion differences (β = −0.43, p = 0.47; Supplementary Figure 5), providing additional evidence for SST cell-specific vulnerability highlighted by bulk tissue analysis.